• Best stocks to buy now
  • Contact
  • Disclaimer
Friday, June 2, 2023
No Result
View All Result
Best Stocks
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones today
    • Pre-IPO and startups
    • Tech stocks
    • Utility stocks
  • Best Stocks toolsHOT
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Social Sentiments Checker
    • Indices
  • About us
    • About
    • Contact
Best Stocks
No Result
View All Result
Home News

Cantor Fitzgerald Analyst Reaffirms Overweight Rating and Price Target for Eli Lilly

Yasmim Mendonça by Yasmim Mendonça
May 26, 2023
in News
Reading Time: 2 mins read
A A
0
Pharmaceuticals market stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On May 26, 2023, Cantor Fitzgerald analyst Louise Chen reaffirmed her recommendation of Eli Lilly (NYSE:LLY) as Overweight and upheld a price target of $485. This aligns with earlier reports from April 2023, where Cantor Fitzgerald sustained coverage of Eli Lilly with an Overweight recommendation and an average one-year price target of $390.96. Despite this, Eli Lilly’s stock closed at $383.35 on April 24, 2023, which is presently below the new price target of $485.

Eli Lilly and Companys Stock Performance and Future Prospects in 2023

On May 26, 2023, Eli Lilly and Company (LLY) opened at $425.38, slightly lower than the previous day’s closing price of $427.31. Throughout the day, the stock fluctuated within a range of $423.67 to $431.54, with a volume of 1,148,032 shares traded.

Eli Lilly and Company’s market capitalization remains strong at $419.9 billion, indicating that investors have confidence in the company’s future prospects. The company has also shown impressive earnings growth over the past year, with a growth rate of 12.53%.

Eli Lilly and Company’s revenue growth rate over the past year has been modest, at 0.79%. However, the company’s price-to-earnings (P/E) ratio is relatively high, at 67.7, compared to the industry average of 22.

On May 26, 2023, Eli Lilly and Company’s stock performance was mixed compared to its peers in the industry.

Looking ahead, Eli Lilly and Company’s next reporting date is August 8, 2023, with an earnings per share (EPS) forecast of $1.99 for this quarter.

Eli Lilly and Co (LLY) Stock Forecast: Analysts Predict 8.97% Increase in Median Target Price

On May 26, 2023, Eli Lilly and Co (LLY) stock closed at $425.80. According to data from CNN Money, 22 analysts have offered 12-month price forecasts for LLY, with a median target of $464.00. The high estimate is $507.00, while the low estimate is $300.00. The median estimate represents an 8.97% increase from the last price of $425.80.

The current consensus among 25 polled investment analysts is to buy stock in Eli Lilly and Co. This rating has held steady since May, when it was unchanged from a buy rating. This suggests that analysts are optimistic about the future of LLY stock.

Looking at LLY’s current quarter earnings per share, the company reported $1.99. Its sales for the quarter were $7.5 billion. LLY is set to report its next earnings on August 08, 2023.

Overall, LLY’s stock performance on May 26, 2023, is reflective of the company’s strong financials and positive outlook from analysts. With a consensus rating to buy the stock and a median target price of $464.00, investors may see potential for growth in the future.

Yasmim Mendonça

Yasmim Mendonça

Yasmine's focus is on uncovering early-stage ideas with the potential to have a lasting impact. Her educational background includes a bachelor's degree in finance, an MBA, and two tests completed - the CFA and CMT.

Discussion about this post

DISCLAIMER

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

READ MORE

Categories

Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks

Data and Tools
Stock Forecast
Dow Jones Today

Follow us on Social Media
Facebook – YouTube – Twitter

Write for us
Finance – Business

Best Stocks to Buy Now

We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

  • Disclaimer
  • Privacy Policy
  • Best stocks to buy now
  • Contact
  • Write for us – Finance, Crypto

© 2023 Best Stocks

No Result
View All Result
  • Home
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech stocks
    • Utility Stocks
  • Best Stocks Tools
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Social Sentiments Checker
    • Indices
  • About us
    • About
    • Contact

© 2023 Best Stocks